Archive for June, 2011

American Health Care: Curbing Costs and Increasing Access

A recent Wall Street Journal article reported that, facing increasing health care costs and higher insurance company  premiums, Americans are patronizing more affordable and convenient retail clinics.  At the same time, Drug Store News disclosed a 36% rise in visits to MinuteClinics last year.

Quick-Care Clinics
The first CVS owned MinuteClinic opened in the Twin Cities in 2000 and now number 560 units in 25 states.  Service is on a walk-in, non-appointment basis, and is administered by family nurse practitioners and physician assistants.  The staff is trained to diagnose and treat common illnesses, minor injuries, and skin conditions deliver health screenings and vaccinations.

Mass Market Retailers Offering Medical Care
Retailers such as Target, Walmart, and ShopKo have joined the express-clinic trend with in-store facilities.  Walmart has gone the route of partnering with local hospitals and leasing out space to medical clinic companies such as Saltanic, which has doctors on staff and offers a wider range of services including x-rays.

Target has taken a slower, more experimental approach after closing the MinuteClinics it had opened in a limited number of stores. This year, the Minneapolis-based retailer undertook the greatest expansion in in-store clinics since 2007, opening eight new Target Clinics – five in Chicago and three in Palm Beach, FL.  Previously the company had operated 28 clinics in just two states: Minnesota and Maryland.

Risks and benefits
Many in the American health care industry worry that offering medicine on a retail basis will result in the commoditization of health care.  However, the upside may be worth the risk.  The reality is that increasing competition by adding another channel of distribution may provide convenience and access to more people.  And that is what is currently missing from health care delivery in America, namely the typical convenience of other services that are subject to free-market forces.

Abbott Baxter Infus O.R IV infusion pump (pre-owned) Call Us at 800-522-5909, ext. 104 for a price quote.
Modify dose without multiple reprogramming steps; adjust settings easily at any time during infusion; change dial settings with a single hand for an immediate response; save calculation time; minimize risk of calculation error.  Read more.

Abbott Baxter Plum 6200 IV infusion pump (pre-owned) Call Us at 800-522-5909, ext. 104 for a price quote.
Baxter 6200 infusion pumps are capable of delivering a wide variety of fluids, including blood, over a broad range of infusion rates.  The 6200s are easy to load, spill resistant pumping mechanisms with occlusion sensors that detect both upstream and downstream restrictions. Read more.

Alaris Asena Tiva IV infusion pump (pre-owned) Call Us at 800-522-5909, ext. 104 for a price quote.
Infusion rates 0.1-1200ml/h; medical device interface (MDI); pole clamp; real-time clock; syringe sizes 5, 10, 20, 30 & 50ml; event log. Read more.


New Victory in the War against Cancer

Amazing progress has been made this year toward prolonging the lives of patients with advanced skin cancer.  In March the U.S. Food and Drug Administration approved Bristol-Myers Squibb’s injectable drug Yervoy, which was found to extend the lives of end-stage melanoma patients an average of 10 months.  In a study which was presented on June 5 at a meeting of the American Society of Clinical Oncology, another drug, vemurafenib, was revealed to have a 63% reduction in the risk of death compared to patients given the chemotherapy drug dacarbazine.

Unlike chemotherapy, which attacks cancer cells with chemicals, Yervoy belongs to a novel class of immuno-therapy drugs that work by mobilizing the body’s immune system to destroy the cancer. Vemurafenib is a so-called targeted therapy which counteracts the effect of a mutation in a gene called B-RAF that causes tumors to grow and spread.

More than life extension
Some observers believed that prolonging the life of patients with metastatic melanoma as much as two years is not significant.  “Two years is nothing when you’re 30,” said Dr. Anna C. Pavlick, head of the melanoma program at New York University.

However, many doctors and patient groups welcomed the progress because until now treatment of melanoma that had spread beyond the skin to other organs was uncontrollable.  “Late-stage melanoma is devastating, with very few treatment options for patients, none of which previously prolonged a patient’s life,” Richard Pazdur, MD, director of the FDA’s cancer drugs office, said in a news release.

The number of melanoma cases has been rising steadily, unlike for many other types of cancer.  Doctors say this is because of unprotected sun exposure and the proliferation of tanning salons.  More than 68,000 people in the United States and 160,000 worldwide are diagnosed with melanoma each year, according to the American Cancer Society.  The five-year survival rate for the aggressive cancer is just 15%.

First in a Series
These two new drugs, with possible rare exceptions, do not cure melanoma.  More than half of patients with the disease will not be helped much or at all by either drug.  Experts say more needs to be done, especially since melanoma affects more young adults than many other types of cancer.

However, Tim Turnham, director of the Melanoma Research Foundation told the Associated Press, “Clearly this is not a home run, but it’s a solid base hit, and because we see other things in the pipeline, we think this is the first in a series of important new therapies for melanoma.”

Brand-new Schiller AT-2 Plus EKG at an amazing price of $1,999.00 – while supplies last. 
Alphanumeric keyboard 6/12 channel representation of all 12 simultaneously acquired leads; large, high resolution backlit monitor for easy preview of ECG quality; automatic and manual mode; fullsize 8 ½” x 11” reports; integrated rechargeable battery lasts up to 3 hours or normal use.  Read more.

GE MAC 1200 EKG machine (pre-owned) $2,200
Resting ECG system whose true one-button operation makes it especially suitable for routine use in private practice, emergency medicine or hospitals; standard, built-in battery; independent battery operation together with the electrode application system KISS with device-integrated suction pump (optional); brilliant graphic display where 12 leads can be displayed quickly in 3-lead sequences. Read more.

Burdick ATIRA 3100 EKG machine (pre-owned) $3,500
Automatic, manual or 12-lead rhythm operation for maximum flexibility; advanced functionality in a compact package; easy-to-use keyboard and menu driven interface; optional, powerful interpretation algorithm based on five clinically significant criteria, as well as pediatric analysis and pacemaker enhancement.  Read more.

refurbished anesthesia machine
Ganim Medical's selection of pre-owned and refurbished medical equipment and furniture can save you hundreds, sometimes thousands of dollars over purchasing new. Click on the above image to view our product offer.
Our biomedical engineering technicians are highly skilled specialists who not only repair medical equipment but also take preventive measures to ensure that your equipment doesn't malfunction at critical moments. Click on the above image for more information.